Medical/Pharmaceuticals News & Press Release Distribution

AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests

GUANGZHOU, China, Nov. 13, 2023 /PRNewswire/ -- AnchorDx, a leading diagnostics company developing cancer early detection tests, announced today that it has entered into a long-term collaboration with DiaCarta, a precision molecular diagnostics company and developer of novel oncology and infectio...

2023-11-13 21:00 1034

AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests

GUANGZHOU, China, Nov. 13, 2023 /PRNewswire/ -- AnchorDx, a leading diagnostics company developing cancer early detection tests, announced today that it has entered into a long-term collaboration with DiaCarta, a precision molecular diagnostics company and developer of novel oncology and infectio...

2023-11-13 21:00 1274

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE

* PYC has developed a new drug candidate for the >5 million people worldwide [1] with Polycystic Kidney Disease (PKD) * This drug candidate has demonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2] * PKD is a life-changing diseas...

2023-11-13 21:00 1162

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Bylvay (odevixibat) is the first and only oral treatment available in Canada for the treatment of pruritus due to this rare genetic condition ZUG, Switzerland and PARIS, Nov. 13, 2023 /PRNewswire/ -- Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical c...

2023-11-13 20:20 1113

TB Alliance Applauds Macleods' Launch of a Key Component of WHO-Recommended Drug-Resistant TB Treatment Regimen

Macleods becomes second pharmaceutical manufacturer to bring pretomanid supply to market and first since the World Health Organization issued updated DR-TB treatment guidelines NEW YORK, Nov. 13, 2023 /PRNewswire/ -- Indian pharmaceutical company Macleods has become the second manufacturer to la...

2023-11-13 18:31 1124

BizLink once again proves its ability to innovate in healthcare robotics

At the MEDICA show in Duesseldorf, BizLink presents its new PULSAR platform, an ultrasafe and precise range of robotic arms for medical para-medical applications. CHARTRES, France, Nov. 13, 2023 /PRNewswire/ -- BizLink, a leading global interconnect solutions provider, announced the introduction...

2023-11-13 17:53 1354

BizLink once again proves its ability to innovate in healthcare robotics

Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery

MELBOURNE, Australia and PARIS, Nov. 13, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) andParis-based Mauna Kea Technologies (Euronext Growth: ALMKT,Mauna Kea), today announce an expansion of the IRiS (Imaging and Robotics in Surgery) Alliance[1] through a stra...

2023-11-13 16:27 1219

Nona Biosciences Announces Strategic Collaboration with GeneQuantum Healthcare to Empower Early Discovery of Next-Generation Bioconjugates

CAMBRIDGE, Mass., Nov. 13, 2023 /PRNewswire/ -- Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, today announced that it has entered into a strategic collaboration with GeneQuantum Healthcare to advance the early discovery of next-gener...

2023-11-13 16:04 1143

Fundiin partners with Pharmacity to launch BNPL at a thousand drugstores in Vietnam

Fundiin and Pharmacity have forged the first-ever Buy Now Pay Later (BNPL) partnership in the pharmacy retail sector, with Fundiin being the most popular BNPL provider inVietnam and Pharmacity emerging as the regional leading drugstore chain. HO CHI MINH CITY, Vietnam, Nov. 13, 2023 /PRNewswire/...

2023-11-13 14:58 1904

Fundiin partners with Pharmacity to launch BNPL at a thousand drugstores in Vietnam

USgHIFUa: a listed Operation at public hospitals

and available at Cornwall Medical in the private sector HONG KONG, Nov. 13, 2023 /PRNewswire/ -- "High intensity focused ultrasound ablation of lesion of uterus using ultrasound guidance" has been included as an "Operation" categorized under "INTERMEDIATEII" on the "List of Private Services"[i] ...

2023-11-13 09:00 1141

Ascletis Announces Poster Presentations at AASLD Annual Meeting 2023 Including a Late-Breaking Abstract of Interim Results from Phase IIb Expansion Cohort of ASC22 for Functional Cure of CHB

HANGZHOU and SHAOXING, China, Nov. 13, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces late-breaking abstract poster presentation of interim results from Phase IIb expansion cohort of ASC22 (Envafolimab) for functional cure of chronic hepatitis B (CHB), and abst...

2023-11-13 08:10 1888

Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea

SINGAPORE, Nov. 13, 2023 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center inSouth Korea. Colorectal cancer (CRC) is o...

2023-11-13 08:00 2281

First Patient Dosed in Phase III ProstACT GLOBAL Study of Antibody-based Prostate Cancer Therapy Candidate, TLX591

MELBOURNE, Australia, Nov. 13, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in the Company's Phase III ProstACT GLOBAL study of its investigational prostate-specific membrane antigen (PSMA) targeting radio...

2023-11-13 07:38 1202

Gillette & Braun sign Major Partnership with Movember

SYDNEY, Nov. 13, 2023 /PRNewswire/ -- In Australia, one in five men will be diagnosed with prostate cancer in their lifetime. One man globally dies by suicide every minute. Testicular cancer is the most common cancer among younger men. This November, Procter & Gamble's leading grooming brands Gi...

2023-11-13 05:30 1821

Fapon Inaugurates State-of-the-Art R&D Center in Lexington, MA

LEXINGTON, Mass., Nov. 11, 2023 /PRNewswire/ -- Fapon, a global leading life sciences organization, is thrilled to announce the grand opening of its US-based Research and Development (R&D) Center, strategically located in Lexington, Massachusetts. This Center represents Fapon's unwavering commitme...

2023-11-11 20:36 2671

SeekIn Presents Retrospective and Prospective Validation Studies of SeekInCare Multi-omics Multi-cancer Early Detection test at the 20th ICGC Workshop and 7th ARGO Meeting in New York

One Retrospective Cohort, One Prospective Cohort, in Total of ~2,400 Cancer Patients and Non-cancer Individuals Demonstrate the Performance of SeekInCare Test to Detect Multiple Cancer Types and Predict Tissue of Origin of Cancers The Achievement of 65.5% Sensitivity at 97.9% Specificity in the ...

2023-11-10 21:00 1796

Seegene Earns Improved ESG Rating from the Korea Institute of Corporate Governance and Sustainability

Company attributes B+ rating to progress related to its Human Rights Management Declaration, eco-friendly shipping box and the establishment of an internal ESG Committee SEOUL, South Korea, Nov. 10, 2023 /PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean company providing a total so...

2023-11-10 20:00 3420

Shaping Global Policy: IFPA's Psoriatic Disease Response Index in the Western Pacific

STOCKHOLM, Nov. 10, 2023 /PRNewswire/ -- Psoriatic disease, recognized as a serious noncommunicable disease by the World Health Organization (WHO), impacts millions worldwide. A pioneering advocacy tool, the Psoriatic Disease Response Index, has emerged to facilitate a vital policy discussion, dr...

2023-11-10 19:18 3472

Shaping Global Policy: IFPA's Psoriatic Disease Response Index in the Western Pacific

Lecheng, MSD vow to deepen medical cooperation

BEIJING, Nov. 10, 2023 /PRNewswire/ -- A news report from chinadaily.com.cn: MSD (Hainan) Innovative Medical Co Ltd is launched on Nov 6 during this year's CIIE. [Photo provided to chinadaily.com.cn] During the 6th China Int...

2023-11-10 18:03 2224

Lecheng, MSD vow to deepen medical cooperation

H2U Secures Strategic Investment from InnoTherapy as Recognition from Seoul Clinical Laboratories (SCL)

H2U platform enters the South Korean healthcare sector, driving AI-powered data analytics to expand their digital health offerings TAIPEI, Nov. 10, 2023 /PRNewswire/ -- H2U, Taiwan's premier digital health brand, proudly announced another successful round of funding this year after receiving rec...

2023-11-10 17:48 2336